PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
Leiden University
Leiden, HolandaPublicaciones en colaboración con investigadores/as de Leiden University (4)
2020
-
Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines
Journal of the European Academy of Dermatology and Venereology
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
2015
-
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model
Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773
2006
-
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
European Journal of Cancer, Vol. 42, Núm. 8, pp. 1014-1030